← Back to all trials
Not Yet Recruiting
NCT07451379
Comparison of Liver Biopsy Versus Fibroscan With CAP ( Controlled Attenuation Parameter) in Donors Evaluation for Liver Transplant
Conditions: Non-invasive Donor Liver Assessment
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Enrollment: 100
Sponsor: Assiut University
Summary
In our study we aiming that liver biopsy histological analysis as a reference standard, to examine the precision of fbroscan controlled attenuation parameter (CAP) for quantitative evaluation of macrovesicular steatosis in living related liver donors.
Eligibility Criteria
Inclusion Criteria:
* All donors aged \>18 years old
* eligible for Liver Transplant
Exclusion Criteria:
* -Subjects aged ≤18 years old.
* Donors refused to do FibroScan with CAP
Source: ClinicalTrials.gov (NCT07451379). StuddyBuddy aggregates publicly available trial information.
